BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 2053665)

  • 1. Cervical cancer screening: who is not screened and why?
    Harlan LC; Bernstein AB; Kessler LG
    Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of fatalism on self-reported use of Papanicolaou smears.
    Chavez LR; Hubbell FA; Mishra SI; Valdez RB
    Am J Prev Med; 1997; 13(6):418-24. PubMed ID: 9415785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers.
    Finney MF; Tumiel-Berhalter LM; Fox C; Jaén CR
    Ethn Dis; 2006; 16(4):994-1000. PubMed ID: 17061758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States.
    Wee CC; Phillips RS; McCarthy EP
    Obes Res; 2005 Jul; 13(7):1275-80. PubMed ID: 16076999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.
    Fletcher FE; Buchberg M; Schover LR; Basen-Engquist K; Kempf MC; Arduino RC; Vidrine DJ
    AIDS Care; 2014; 26(10):1229-35. PubMed ID: 24635664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
    Hewitt M; Devesa S; Breen N
    Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of cervical cancer screening among underserved Hispanic and African-American women.
    Bazargan M; Bazargan SH; Farooq M; Baker RS
    Prev Med; 2004 Sep; 39(3):465-73. PubMed ID: 15313085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs about sexual behavior and other predictors of Papanicolaou smear screening among Latinas and Anglo women.
    Hubbell FA; Chavez LR; Mishra SI; Valdez RB
    Arch Intern Med; 1996 Nov; 156(20):2353-8. PubMed ID: 8911242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.
    Frazier EL; Sutton MY; Tie Y; McNaghten AD; Blair JM; Skarbinski J
    J Womens Health (Larchmt); 2016 Feb; 25(2):124-32. PubMed ID: 26447835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic predictors of adherence to annual cervical cancer screening in minority women.
    Jennings-Dozier K; Lawrence D
    Cancer Nurs; 2000 Oct; 23(5):350-6; quiz 357-8. PubMed ID: 11037955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap smear use in California: are we closing the racial/ethnic gap?
    De Alba I; Ngo-Metzger Q; Sweningson JM; Hubbell FA
    Prev Med; 2005 Jun; 40(6):747-55. PubMed ID: 15850875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of patient race/ethnicity, insurance and age on Pap smear compliance across ten community health centers in Florida.
    Cook N; Kobetz E; Reis I; Fleming L; Loer-Martin D; Amofah SA
    Ethn Dis; 2010; 20(4):321-6. PubMed ID: 21305816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.